|
Project Title:
|
Identifying and Preventing Medication Errors
|
|
PIN:
|
HCSX-H-04-03-A
|
Major Unit:
|
Institute of Medicine
|
|
Sub Unit:
|
Board on Health Care Services
|
|
RSO:
|
Aspden, Philip
|
|
Subject/Focus Area:
|
|
|
|
Project Scope
|
For the purposes of this study, a "drug" includes prescription drugs and
biologics, excluding blood and blood products and tissues for transplantation.
The objectives of the study are:
1. To develop a fuller understanding of drug safety and quality issues
through the conduct of an evidence-based review of the literature, case studies
and analysis. This review will consider the nature and causes of medication
errors; their impact on patients; and the differences in causation, impact and
prevention across multiple dimensions of health care delivery including patient
populations, care settings, clinicians, and institutional cultures.
2. If possible, to develop estimates of the incidence, severity and
costs of medication errors that can be useful in prioritizing resources for
national quality improvement efforts and influencing national health care
policy.
3. To evaluate alternative approaches to reducing medication errors in
terms of their efficacy, cost-effectiveness, appropriateness in different
settings and circumstances, feasibility, institutional barriers to
implementation, associated risk, and quality of evidence supporting the
approach.
4. To provide guidance to consumers, providers, payers, and other key
stakeholders on high-priority strategies to achieve both short-term and
long-term drug safety goals, to elucidate the goals and expected results of
such initiatives and support the business case for them, and to identify
critical success factors and key levers for achieving success.
5. To assess opportunities and key impediments to broad nationwide
implementation of medication error reductions, and to provide guidance to
policy-makers and government agencies in promoting a national agenda for
medication error reduction.
6. To develop an applied research agenda to evaluate the health and cost
impacts of alternative interventions, and to assess collaborative public and
private strategies for implementing the research agenda through AHRQ and other
government agencies.
Sponsor: U.S. Department of Health and Human Services, Centers for Medicare
and Medicaid Services
The approximate starting date for the project is 09/01/2004.
The committee will produce one report in Spring 2006.
|
|
|
| |
|
Project Duration:
|
20 months
|
Provide FEEDBACK on this project.
|
Contact the Public Access Records Office to make an inquiry, request a list of the public access file materials, or obtain a copy of the materials found in the file.
|
|
|
Tel:
202.334.2000